Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CoreHip - Post Market Clinical Follow-Up Study

NCT: NCT03685110 · ACTIVE_NOT_RECRUITING

NCT IDNCT03685110
StatusACTIVE_NOT_RECRUITING
Start Date2018-10-16
Completion2028-12

Brief Summary

The study is designed as a prospective, non-interventional multicentre cohort study. The product under Investigation will be used in Routine clinical practice and according to the authorized Instructions for Use (IfU). Aim of this observational study is to collect clinical and radiological results of the CoreHip® endoprosthesis system in a Standard Patient Population and when used in Routine clinical practice.

Frequently Asked Questions

What is CoreHip - Post Market Clinical Follow-Up Study?

CoreHip - Post Market Clinical Follow-Up Study is a clinical trial registered under NCT03685110. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03685110?

The current status of NCT03685110 (CoreHip - Post Market Clinical Follow-Up Study) is: ACTIVE_NOT_RECRUITING.

When did CoreHip - Post Market Clinical Follow-Up Study start?

CoreHip - Post Market Clinical Follow-Up Study started on 2018-10-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.